n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with sq-23377 in 1 studies
Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
---|---|---|---|---|---|
79 | 1 | 16 | 4,385 | 10 | 493 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fagan, JM; Waxman, L | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and sq-23377
Article | Year |
---|---|
The ATP-independent pathway in red blood cells that degrades oxidant-damaged hemoglobin.
Topics: Adenosine Triphosphate; Animals; Azides; Calcimycin; Cations, Divalent; Cysteine Proteinase Inhibitors; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Hemoglobins; Hydrogen Peroxide; Ionomycin; Kinetics; Leucine; Male; Oxidants; Phenylhydrazines; Pyrimidinones; Rabbits; Rats | 1992 |